DUBLIN–(BUSINESS WIRE)–The “Global Osimertinib Drugs Market: by Type by Application and by Region – Forecast and Estimation for 2017-2027” report has been added to ResearchAndMarkets.com’s offering.
Global Osimertinib drugs market is expected to reach US$ 11,839.8 million by 2027 at a CAGR of 16.1%, from US$ 4828.6 million in 2021, according to a new report.
Osimertinib is a receptor tyrosine kinase inhibitor that has shown promise in treating multiple types of cancer. The drug has been shown to be safe and effective when used as prescribed, and is already being used to treat small cell lung cancer. In recent years, the demand for Osimertinib drugs has grown rapidly due to the positive clinical results seen in cancer patients. This growth is believed to be due to the drug’s adverse effects being manageable when used as prescribed, its low price point, and the increasing awareness of the drug’s potential benefits.
The researchers determined that the high demand for Osimertinib drugs was due in part to its unique properties as a double tyrosine kinase inhibitor. Osimertinib is not only effective against tumors with ALCL, but it also targets other types of cancer such as non-small cell lung cancer (NSCLC). In addition, Osimertinib does not require radiation or surgery for treatment, making it a preferable option for some patients.
Market Dynamics
Drivers
There are several reasons why Osimertinib is gaining popularity among patients with NSCLC.
Osimertinib has a relatively low risk of side effects when compared to other treatments available to patients.
Osimertinib has been shown to be an effective treatment in clinical trials and has shown few if any side effects when used in combination with other treatments such as radiation therapy or chemotherapy.
Osimertinib is also inexpensive relative to other treatments available on the market
Segment Overview
By type, the global Osimertinib market is segment into 40mg and 80 mg. Wherein, the 40mg segment is projected to generate a revenue of $8,500 million by 2027.
In 2021, over 13,728,057 tablets of Osimertinib drugs were sold.
By applications, hospitals are estimated to consume over 80% of the global demand. Hospitals are the largest consumer of lung cancer drugs such as Osimertinib, and they account for a large portion of the total prescriptions that are written for these medications. In fact, more than 80 percent of all prescription pneumonectomy drugs are taken by hospitals. The vast majority of these medications are used to treat advanced lung cancer.
Since the approval of Osimertinib, the drug has seen high demand from hospitals for its use in treating cancer. Hospitals have been able to find success using Osimertinib to treat a variety of cancers including lung cancer. The reason for the high demand is that Osimertinib is a targeted therapy that specifically kills cancer cells. Cancer cells are able to resist regular treatments such as chemotherapy, so doctors are often looking for new ways to treat cancer patients.
By Type
40 mg
80 mg
By Application
Hospitals
Drug Stores
By Region
North America
Europe
Asia Pacific
Middle East & Africa
South America
Global Osimertinib market Report Answers Questions Such As:
What is the market size and forecast of the Global Osimertinib market?
What are the inhibiting factors and impact of COVID-19 on the Global Osimertinib market during the assessment period?
Which are the products/segments/applications/areas to invest in over the assessment period in the Global Osimertinib market?
What is the competitive strategic window for opportunities in the Global Osimertinib market?
What are the technology trends and regulatory frameworks in the Global Osimertinib market?
What is the market share of the leading players in the Global Osimertinib market?
What modes and strategic moves are considered favorable for entering the Global Osimertinib market?
Key Topics Covered:
Chapter 1 Osimertinib Drugs Market Scope
Chapter 2 Global Osimertinib Drugs Market Dynamics and Overview
Chapter 3 Global Osimertinib Drugs Market Analysis, by Region
Chapter 4 Global Osimertinib Drugs Market Analysis, by Type
Chapter 5 Global Osimertinib Drugs Market Analysis, by Application
Chapter 6 North America Osimertinib Drugs Market Analysis
Chapter 7 Asia Pacific Osimertinib Drugs Market Analysis
Chapter 8 Europe Osimertinib Drugs Market Analysis
Chapter 9 South America Osimertinib Drugs Market Analysis
Chapter 10 MEA Osimertinib Drugs Market Analysis
Chapter 11 Company Profiles
Chapter 12 OSIMERTINIB DRUGS MANUFACTURING COST ANALYSIS
Chapter 13 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
Chapter 14 Research Methodology
Companies Mentioned
AstraZeneca
For more information about this report visit https://www.researchandmarkets.com/r/u1ukip
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
